New Techno-Innovative Developments Influencing Elastography Imaging Market to Establish a Perfect Double-Digit CAGR of 11.1% During Forecast 2019-2025

Market Highlights:

It is estimated that the global Elastography Imaging Market is expected to register a CAGR of 11.1% during the forecast period of 2019 to 2025, with a market value of USD 2,538.2 million in 2018.
Elastography is a medical imaging method that plots the elastic properties of soft tissue to stipulate the diagnostic data during surgery. The elastography imaging market is fueled by numerous factors such as growing demand for minimally invasive procedures to diagnose and treat different chronic diseases, along with the rising prevalence of life-threatening diseases. However, the high cost of the systems is expected to curb the growth of the elastography imaging market.
The global elastography imaging market is currently dominated by numerous market players. The key players are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in February 2019, Esaote launched the MyLabX8, an ultrasound platform to support hospitals and clinics. Also, in November 2018, Canon Medical Systems Corporation introduced Contrast Vector Imaging (CVI) to provide additional information on liver hemodynamics and expand the use of contrast-enhanced ultrasound on its premium ultrasound system.

Access Report Details and TOC Details Exclusively  @ https://www.marketresearchfuture.com/reports/elastography-imaging-market-8070

Key Players:
·         Canon Medical Systems Corporation
·         Siemens AG
·         Fujifilm Holdings Corporation
·         Esaote, Resoundant Inc
·         Hitachi Ltd
·         Mindray Medical International Ltd
·         Koninklijke Philips N.V
·         Samsung Electronics (Samsung Medison)
·         Supersonic Imagine

Segmentation:
·         The global elastography imaging market has been segmented based on modality, application, and end user.
·         The market, based on modality, has been bifurcated into ultrasound, and magnetic resonance elastography. The ultrasound segment is expected to hold a major share in the market, owing to the high advantages of this type of modality. The magnetic resonance elastography segment is anticipated to be the fastest growing due to the wider availability and rising adoption rate.
·         The market, by application, has been divided into radiology/general imaging, cardiology, obstetrics/gynecology, urology, vascular, orthopedic & musculoskeletal applications, and others.
·         The market, by end user, has been classified as hospitals & ambulatory surgical centers, diagnostic centers, research laboratories, and others.

Regional Analysis:
The market in the Americas is likely to lead the global elastography imaging market during the assessment period owing to the increasing per capita healthcare expenditure, and the heavy adoption of new technology in the region. Additionally, the increase in the insurance coverage and improving reimbursement scenario in the US and Canada are also projected to drive the growth of the market.
Europe is expected to hold the second largest position in the global elastography imaging market. The market growth in this region is because of the presence of a well-established healthcare system, an increase in life-threatening diseases, and the active involvement of major players. For instance, in May 2017, Esaote expanded its ultrasound sales team in the UK.
The market in Asia-Pacific is projected to have a steady growth rate during the forecast period owing to the increasing number of patients with chronic diseases and government initiatives for healthcare reforms. However, a decrease in capital investment is restricting the market growth of this region.

About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more